Update Breast Cancer 2022 Part 5 - Early Stage Breast Cancer

Tanja N Fehm1, Manfred Welslau2, Volkmar Müller3

  • 1Department of Gynecology and Obstetrics, University Hospital Düsseldorf, Düsseldorf, Germany.

Insights

Recent advancements in early-stage breast cancer treatment include new drugs like pembrolizumab and updated findings on neoadjuvant atezolizumab and dynamic Ki-67. This review covers key data from ESMO 2022 and recent publications.

Area of Science:

  • Oncology
  • Medical Research

Background:

  • Early-stage breast cancer treatment has evolved with novel therapies.
  • Pembrolizumab, olaparib, and abemaciclib represent significant therapeutic advancements.

Purpose of the Study:

  • To review recent findings in early-stage breast cancer treatment.
  • To summarize key data presented at major conferences and in recent publications.

Main Methods:

  • Literature review of recent publications and conference presentations (e.g., ESMO 2022).
  • Inclusion of data on novel drug classes, genetic discoveries, and therapeutic approaches.

Main Results:

  • Updates on pembrolizumab, olaparib, and abemaciclib in breast cancer.
  • New insights into neoadjuvant atezolizumab for HER2-positive patients.
  • Long-term data from the APHINITY study and prognostic impact of local anesthetics.
  • Presentation of dynamic Ki-67 data from ADAPT studies.

Conclusions:

  • The landscape of early-stage breast cancer management is rapidly advancing.
  • Emerging data highlight the potential of new drugs and therapeutic strategies.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
463
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K